Mirabegron

설명

Mirabegron · CAS 223673-61-8 · C21H24N4O2S. UNII MVR3JL3B2V. European Pharmacopoeia monograph. 용해도: 0.082.

식별 정보

계산된 디스크립터

물리적·화학적 성질

GHS 위험 분류

문헌상 용도

• Mirabegron is indicated for the treatment of overactive bladder (OAB) – with symptoms of urge urinary incontinence, urgency, and urinary frequency – either alone or in combination with [solifenacin]. It is also indicated for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 3 years of age and older and weighing 35kg or more.
• Mirabegron is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome. Mirabegron has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.
• Take with food. While adults may take mirabegron with or without food, prescribing information recommends that children always co-administer mirabegron with food.
• Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.
• Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.
• Established Pharmacologic Class [EPC] – beta3-Adrenergic Agonist

동의어

Mirabegron; 223673-61-8; Myrbetriq; Betanis; Betmiga; YM-178; YM178; MVR3JL3B2V; 2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide; CHEBI:65349; DTXSID101021648; 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide; 2-(2-Aminothiazol-4-yl)-4'-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)acetanilide; 4-Thiazoleacetamide, 2-amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-; 2-(2-AMINO-1,3-THIAZOL-4-YL)-N-(4-(2-(((2R)-2-HYDROXY-2-PHENYLETHYL)AMINO)ETHYL)PHENYL)ACETAMIDE; mirabegronum

자주 묻는 질문

Mirabegron의 CAS 등록번호와 분자식은 무엇입니까?

CAS 223673-61-8; 분자식 C21H24N4O2S; 분자량 — g/mol.

Mirabegron은(는) 다른 어떤 이름으로 알려져 있습니까?

Mirabegron, 223673-61-8, Myrbetriq, Betanis, Betmiga, YM-178.

Mirabegron은(는) 위험물로 분류됩니까?

보고된 위험 문구: H302, H317, H319, H361, H373.

Mirabegron은(는) 약전 모노그래프가 있습니까?

Yes — a monograph exists in the European Pharmacopoeia (Ph. Eur.).

Mirabegron의 주요 물리적 성질은 무엇입니까?

용해도: 0.082.

이 페이지의 정보는 PubChem(미국 국립의학도서관) 및 Wikidata에서 가져왔습니다. 등급별 데이터 — 함량, 수분, 입자 크기, 포장, 유통기한 — 는 각 로트의 COA에 명시되며 여기에 공개되지 않습니다.

가격, COA, 사양은 이메일로 문의하세요